FY'19-RFQ-dyrs-pharmaceutical supply, delivery and service
Closed State & local contract opportunity Posted
- Solicitation number
- Doc414017
- State
- District of Columbia
- Responses due
Opportunity facts
Opportunity details come from contracts.ocp.dc.gov. Updated .
About this opportunity
The District of Columbia has issued a Request for Quotation (RFQ) for pharmaceutical supply, delivery, and service for the Department of Youth Rehabilitation Services (DYRS) for fiscal year 2019. The procurement seeks a vendor capable of providing comprehensive pharmaceutical procurement and distribution services to support the agency's medical and rehabilitation programs. Specific deliverables are expected to include timely supply of pharmaceutical products, reliable delivery mechanisms, and ongoing service support for the department's medical operations. The solicitation was posted on November 27, 2018, with a remarkably short response window, closing on November 29, 2018 - indicating an urgent procurement need. While detailed evaluation criteria are not explicitly provided in the available information, typical pharmaceutical contract assessments often involve vendor qualifications, pricing structures, delivery capabilities, product quality, and compliance with healthcare procurement regulations.
Based on the limited information provided, no specific set-aside designations or enterprise restrictions are evident in this procurement opportunity. The contract appears to be open to pharmaceutical suppliers and distributors with appropriate licensing and capabilities to serve a youth rehabilitation services agency. Without explicit budget details, the potential award value remains undetermined, though government pharmaceutical contracts typically range from moderate to substantial financial commitments. The brief solicitation timeline suggests the District of Columbia is seeking an expedited procurement process to address immediate pharmaceutical supply needs for the Department of Youth Rehabilitation Services. Potential respondents would likely need to demonstrate robust pharmaceutical distribution infrastructure, regulatory compliance, and the ability to quickly mobilize medical supply resources for an institutional healthcare setting.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity